drugset / Trial / NCT00609596

A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.

NCT00609596

Phase 1 Completed 24 enrolled GlaxoSmithKline
RandomizedCrossoverOpen-labelTreatment

Summary

Dutasteride and tamsulosin are to treat benign prostatic hyperplasia. Studies show that when given together, there is more improvement in symptoms than either drug alone. In this study, we are looking to see if 2 different formulations of tamsulosin in our combination capsules are the same after 7 days of dosing as the US commercial tamsulosin and dutasteride.

Timeline

Start
2008-02-26
Primary completion
2008-04-23
Completion
2008-04-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Tamsulosin Other / unclassified
Background Dutasteride Small molecule